Compare NTSK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTSK | HAE |
|---|---|---|
| Founded | 2012 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2025 | 1996 |
| Metric | NTSK | HAE |
|---|---|---|
| Price | $24.28 | $118.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | $19.36 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 5.4M | 607.7K |
| Earning Date | 12-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.64 | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $708,997,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $25.60 | $6.21 |
| Revenue Next Year | $21.14 | $5.54 |
| P/E Ratio | ★ N/A | $162.15 |
| Revenue Growth | ★ 31.72 | N/A |
| 52 Week Low | $7.67 | $48.98 |
| 52 Week High | $24.98 | $123.77 |
| Indicator | NTSK | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 74.85 | 64.22 |
| Support Level | $8.67 | $100.92 |
| Resistance Level | N/A | $123.77 |
| Average True Range (ATR) | 1.32 | 3.68 |
| MACD | 0.25 | -0.20 |
| Stochastic Oscillator | 98.91 | 77.24 |
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.